Amarin Corp Plc (AMRN)

[ggwpq]

I think Amarin should stress that, in its concluding remark, it cost lots of money to run the CVOT, especially given its limited financial resources. However, in order to be able to serve an unmet medical need, the company is determined to see Reduce-It to conclusion using all means possible. Given Vascepa's proven safety & efficacy, its an educated gamble worth to take.